20990 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Hormones Prolactin
Method and System for Tuning Hormone Receptors through the Dynamic Intravenous Delivery of a Hormone According to a Target Physiological Cadence
#2COMPOSITIONS FOR TREATING INFLAMMATORY AIRWAY DISEASE AND USES THEREOF
#3NEUROPROTECTIVE COMPOSITIONS AND USE THEREOF
#4PEPTIDES AND USES THEREOF
#5NEUROPROTECTIVE COMPOSITIONS AND USE THEREOF
#6Prolactin Delivering Nerve Wrap
#7Taxane- and Taxoid-Protein Compositions
#8FOOD CONTAINING PROLACTIN
#9COMPOSITIONS AND METHODS FOR THE TREATMENT OF SEXUAL DYSFUNCTION
#10LIPIDATED PEPTIDES AS ANTI-OBESITY AGENTS
#11Lipidated peptides as anti-obesity agents
#12FOOD CONTAINING PROLACTIN
#13Method for treating breast cancer with prolactin receptor agonists
#14Use of Prolactin Receptor Antagonist and Chemotherapeutic Drug for Treating Ovarian Cancer
#15Method for sensitizing cancer stem cells to cancer therapy
#16PHARMACEUTICAL COMPOSITION FOR TREATMENT OF THROMBOSIS-RELATED DISEASES COMPRISING A FRAGMENT OF PROLACTIN (PRL)-GROWTH HORMONE (GH)-PLACENTAL LACTOGEN (PL)-FAMILY PROTEIN
#17Prolactin Induced Increase in Neural Stem Cell Numbers
#18Treating or ameliorating some neuroendocrine disorders in male with help of prolactin
#19Pheromones and the luteinizing hormone for inducing proliferation of neural stem cells and neurogenesis
#20Viral vector encoding a toll-like receptor and encoding a toll-like receptor agonist
#21Stimulation of proliferation of pluripotential stem cells through administration of pregnancy associated compounds
#22Pregnancy-induced oligodendrocyte precursor cell proliferation regulated by prolactin
#23FOOD CONTAINING PROLACTIN
#24Prolactin induced increase in neural stem cell numbers
#25METHOD OF INDUCING PROLIFERATION AND/OR DIFFERENTIATION OF NEURAL PRECURSOR CELLS BY INTRODUCING PROLACTIN OR WNT3A TO ACTIVATE LATENT NEURAL PRECURSOR CELLS
#26Taxane- and taxoid-protein compositions
#27Pheromones and the luteinizing hormone for inducing proliferation of neural stem cells and neurogenesis
#28COMPOSITIONS AND METHODS OF STEM CELL THERAPY FOR AUTISM
#29Compositions and methods for visualizing and eliminating cancer stem cells
#30Treating or Ameliorating a Neuroinflammatory or Demyelinating Disorder with Prolactin and Interferon-Beta
#31Compositions and methods for visualizing and eliminating cancer stem cells
#32Use of Prolactin in the Prophylactic Treatment of Cancer
#33Dimeric Prolactin Receptor Ligands
#34Combined Regulation of Neural Cell Production
#35Oligodendrocyte precursor cell proliferation regulated by prolactin
#36METHOD OF PREVENTING AND TREATING ENDOCRINE SYSTEM DISTURBANCES
#37Prolactin induced increase in neural stem cell numbers
#38Method for Inducing Mammary Epithelial Cell Differentiation
#39USE OF A VECTOR COMPRISING A NUCLEIC ACID ENCODING AN ANTI-ANGIOGENIC FACTOR FOR THE TREATMENT OF CORNEAL NEOVASCULARIZATION
#40Methods And Compositions For The Treatment Of Prolactin-Receptor Related Disorders
#41Method of enhancing and/or inducing neuronal migration using erythropoietin
#42Pregnancy-induced oligodendrocyte precursor cell proliferation regulated by prolactin
#43Use of anti-prolactin agents to treat proliferative conditions
#44Variants of mammalian prolactin, prolactin receptor antagonists, and methods of use
#45Effect of growth hormone and IGF-1 on neural stem cells
#46Combined regulation of neural cell production
#47Pheromones and the luteinizing hormone for inducing proliferation of neural stem cells and neurogenesis
#48Stimulation of proliferation of pluripotential stem cells through administration of pregnancy associated compounds
#49Use of prolactin receptor antagonists in combination with an agent that inactivates the HER2/neu signaling pathway
#50Medicinal Agent for Preventing and Treating Endocrine System Disturbances
#51Pheromones and the luteinizing hormone for inducing proliferation of neural stem cells and neurogenesis
#52Animal treatment
#53Method and system for tuning hormone receptors through the dynamic intravenous delivery of a hormone according to a target physiological cadence